Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

被引：0
|
作者：
Cobain, Erin F. [1 ]
Hayes, Daniel F. [1 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 32期
关键词：
PATIENT-LEVEL METAANALYSIS; RIBOCICLIB PLUS FULVESTRANT; CELL-FREE DNA; POSTMENOPAUSAL WOMEN; MUTATIONS; LETROZOLE; SURVIVAL; TRIAL; MULTICENTER; PALBOCICLIB;
D O I：
10.1200/JCO.22.00702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3673 / +
页数：5
相关论文
共 50 条
  • [31] The Impact of Exogenous Estrogen Exposure on the Characteristics and Outcome of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer
    Yariv, Orly
    Mutai, Raz
    Rotem, Ofer
    Tsoref, Daliah
    Korzets, Yasmin
    Moore, Assaf
    Shochat, Tzippy
    Yerushalmi, Rinat
    Goldvaser, Hadar
    ONCOLOGY, 2021, 99 (11) : 713 - 721
  • [32] Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes
    Friedman-Eldar, Orli
    Ozmen, Tolga
    El Haddi, Salah James
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susan B.
    Moller, Mecker G.
    Franceschi, Dido
    Layton, Christina
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4092 - 4101
  • [33] Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes
    Orli Friedman-Eldar
    Tolga Ozmen
    Salah James El Haddi
    Neha Goel
    Youley Tjendra
    Susan B. Kesmodel
    Mecker G. Moller
    Dido Franceschi
    Christina Layton
    Eli Avisar
    Annals of Surgical Oncology, 2022, 29 : 4092 - 4101
  • [34] Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
    Gelmon, Karen A.
    Cristofanilli, Massimo
    Rugo, Hope S.
    DeMichele, Angela M.
    Joy, Anil A.
    Castrellon, Aurelio
    Sleckman, Bethany
    Mori, Ave
    Theall, Kathy Puyana
    Lu, Dongrui R.
    Huang, Xin
    Bananis, Eustratios
    Finn, Richard S.
    Slamon, Dennis J.
    BREAST JOURNAL, 2020, 26 (03): : 368 - 375
  • [35] Advances in endocrine and targeted therapy for hormone-receptorpositive, human epidermal growth factor receptor 2-negative advanced breast cancer
    Shen Le-Sang
    Jin Xiao-Yan
    Wang Xu-Meng
    Tou Lai-Zhen
    Huang Jian
    中华医学杂志(英文版), 2020, 133 (09) : 1099 - 1108
  • [36] Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials
    Regan, Meredith M.
    Francis, Prudence A.
    Pagani, Olivia
    Fleming, Gini F.
    Walley, Barbara A.
    Viale, Giuseppe
    Colleoni, Marco
    Lang, Istvan
    Gomez, Henry L.
    Tondini, Carlo
    Pinotti, Graziella
    Price, Karen N.
    Coates, Alan S.
    Goldhirsch, Aron
    Gelber, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2221 - +
  • [37] Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
    Kim, Min Chong
    Kwon, Sun Young
    Choi, Jung Eun
    Kang, Su Hwan
    Bae, Young Kyung
    JOURNAL OF BREAST CANCER, 2023, 26 (02) : 105 - 116
  • [38] Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
    Jhaveri, Komal
    Marme, Frederik
    CANCER TREATMENT REVIEWS, 2024, 123
  • [39] Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer
    Lim, Seung Taek
    Choi, Hyang Suk
    Kim, Kwangmin
    Hahn, Seok
    Cho, In-Jeong
    Noh, Hany
    Lee, Jong-In
    Han, Airi
    CLINICAL BREAST CANCER, 2023, 23 (07) : e424 - e433.e3
  • [40] Avoidance of Negative Results in Adjuvant Endocrine Therapy Trials for Estrogen Receptor-Positive Breast Cancer
    Goncalves, Rodrigo
    Reinert, Tomas
    Ellis, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2718 - +
12345